AlgaeCytes is a science company focused on using algae to meet the growing demand for health-promoting ingredients and first to benefit from the first phase of Discovery Park’s multi-million pound investment in the science park’s laboratory and GMP manufacturing offer.
AlgaeCytes has developed a process that captures the properties of algae to produce high value ingredients for the health and personal care markets and intends to use its new commercial production facility to scale up production to meet demand.
AlgaeCytes produces high quality Omega-3 oils EPA as well as protein and carbohydrates from algae.
Traditional marine-sources of Omega oils are putting pressure on global fish stocks and thus becoming recognised as unsustainable. Omega 3 oils from non-marine sources are attracting significant interest in the personal care and health care markets.
Naz Bashir, Chief Executive, AlgaeCytes, said: “The opening of this new facility marks an exciting stage for AlgaeCytes that we believe will unlock the full potential of algae in the nutritional and health care markets.
“Our aim is not only to produce a more sustainable source of Omega-3 oils but to create ingredients that amaze; ingredients that will be used in beauty products that can improve skin health.
On the importance of Discovery Park to the company’s future, Naz added: “We are delighted to grow our footprint at Discovery Park and we look forward to continuing our expansion plans.
“We have found the site’s environment and facilities perfect for carrying out our research to date and are very much looking forward to this next phase of our development.”
To find out more visit the AlgaeCytes website.